Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA062500-03
Application #
2103791
Study Section
Special Emphasis Panel (SRC (74))
Project Start
1994-03-01
Project End
1998-01-31
Budget Start
1996-02-01
Budget End
1997-01-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057

  Publications

Marshall, John L; Rizvi, Naiyer; Kauh, John et al. (2002) A phase I trial of depsipeptide (FR901228) in patients with advanced cancer. J Exp Ther Oncol 2:325-32
Marshall, J L; Hawkins, M J; Tsang, K Y et al. (1999) Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen. J Clin Oncol 17:332-7
Wojtowicz-Praga, S; Torri, J; Johnson, M et al. (1998) Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. J Clin Oncol 16:2150-6
Wojtowicz-Praga, S M; Dickson, R B; Hawkins, M J (1997) Matrix metalloproteinase inhibitors. Invest New Drugs 15:61-75
Marshall, J L; Wellstein, A; Rae, J et al. (1997) Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer. Clin Cancer Res 3:2347-54